Breaking News: Pacific General Joins Forces with Broadriver Asset Management to Snag U.S. and Bermuda Platform from Lombard International Group!

Welcome to the Pacific General Closes Co-Investment Blog! Let’s Talk About the Recent Acquisition of Lombard International Group Dec. 14, 2023 Hey there, fellow finance enthusiasts! Have you heard the latest news about Pacific General’s equity participation in the acquisition of Lombard International Group’s U.S. and Bermuda business? This exciting deal, led by BroadRiver Asset…

Read More

Breaking News: Mama’s Creations Inc. Announces Exciting Pricing of Public Secondary Offering of Common Stock by Selling Stockholders!

Mama’s Creations, Inc. Announces Pricing of the Public Secondary Offering of Common Stock by Selling Stockholders East Rutherford, NJ, Dec. 19, 2023 (GLOBE NEWSWIRE) — Mama’s Creations, Inc. (Nasdaq: MAMA), a leading national marketer and manufacturer of fresh Deli prepared foods, has recently made a significant announcement regarding the pricing of a public secondary offering…

Read More

Unlocking the Potential: A Closer Look at the Crucial EUR/USD Level of 1.08 and its Impact on the Market – May 30th Options Expiry

The Intricacies of EUR/USD Exchange Rate EUR/USD Exchange Rate Analysis As of the latest update, the EUR/USD exchange rate is hovering just under 1.08. This significant figure is expected to act as a magnet during the trading session, as there are 2.8 billion strikes at this level on May 30. The Euro remains under pressure…

Read More

Revolutionizing Brand-Customer Relationships: Introducing the G.R.A.V.I.T.Y. Index by Spiro

New Methodology Revealed to Strengthen Brand Loyalty LAS VEGAS, Nov. 2, 2023 /PRNewswire/ — Global brand experience agency Spiro has recently launched its groundbreaking G.R.A.V.I.T.Y. Index™, a unique methodology designed to measure and enhance the bond between brands and their customers. This innovative approach aims to establish enduring connections that not only boost brand loyalty…

Read More

Travere Therapeutics to Showcase Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2024

Travere Therapeutics to Present Exciting Advances in HCU Treatment at SSIEM Symposium SAN DIEGO, Aug. 22, 2024 (GLOBE NEWSWIRE) Travere Therapeutics, Inc., (Nasdaq: TVTX) has made a groundbreaking announcement today, revealing plans to present two posters at the Society for the Study of Inborn Errors of Metabolism (SSIEM) annual symposium in Porto, Portugal from September…

Read More